Back to Journals » Lung Cancer: Targets and Therapy » Volume 7
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,439 | Dovepress* | 8,275+ | 1,583 | 9,858 | |
PubMed Central* | 1,164 | 323 | 1,487 | ||
Totals | 9,439 | 1,906 | 11,345 | ||
*Since 17 June 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed and Google Scholar